Thrombotic microangiopathy after renal transplantation in the United States.
about
Disease recurrence in paediatric renal transplantationDe novo glomerular diseases after renal transplantationDe novo thrombotic microangiopathy following treatment with sirolimus: report of two cases.Thrombotic microangiopathy in the early post-renal transplant period.Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study.A 'silent', new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantationDe novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus.Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literatureThe inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.Hemolytic uremic syndrome after renal transplantationPost transplant thrombotic microangiopathy causing acute renal failureDiffering tales of two patients after receiving a kidney transplant from a donor with disseminated intravascular coagulationDiscrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.Tacrolimus associated localized thrombotic microangiopathy developing in early stage after renal transplantationCharacteristics and Outcomes of Renal Transplant Recipients with Hemolytic Uremic Syndrome in the United States.Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failureAdverse events associated with mTOR inhibitors.Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients.Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants.De novo post-transplant thrombotic microangiopathy localized only to the graft in autosomal dominant polycystic kidney disease with thrombophilia.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Use of mTOR inhibitors in human organ transplantation.A case of atypical hemolytic uremic syndrome in a second renal transplant.Transplant glomerulopathy.Thrombotic Microangiopathy and the Kidney.Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation.Use of belatacept to maintain adequate early immunosuppression in calcineurin-mediated microangiopathic hemolysis post-renal transplantThrombotic microangiopathy after renal transplantation: Current insights in and recurrent disease
P2860
Q24645234-D75A51AA-3DD4-4FC2-923C-4706C08FC525Q27005877-18C99696-8BD7-498F-96F0-8D3B71C9C0DFQ33364407-D9E03A00-5DFB-4395-A29F-A0DCF06F43B2Q33378757-3C163270-CB24-4DF6-AF34-4C3B435E6E85Q33405522-12321631-7F13-4D78-903E-A20339B57C92Q33414342-8DF27888-9EA9-4992-9EC9-1149E1887EFFQ33418553-08B78701-7C19-46C5-8C95-7FF1D3D5EA60Q33419481-10CF9FA7-1C10-4CB1-97D4-03EA23991403Q33419720-0FA469BB-E776-439C-AC75-32941460293CQ33421909-CD2CFA06-142C-4003-A370-E4E2F02C135FQ33426548-A199B51A-6AAF-43F8-9802-7E419D953D89Q33439133-45342144-5594-4C43-9ED2-11B729CECE64Q33598544-ED4ECED1-A376-41D4-9684-DBF284E438E7Q33762761-B418F624-5E78-464F-BDD1-18FCF6FFF47FQ33908301-E1D75E4E-E56E-45BC-BF0E-7BE279370D9CQ34405321-D6152A94-7434-414A-B38A-418E17F2A948Q36554196-0D13B352-4BE5-49A2-ACF5-0D1E095CC6A1Q36641955-24339F07-1FE1-4FA2-B748-A756DB5DE874Q36736632-ADF5F258-8D72-491C-8432-D6E7794A6587Q38068519-9FA5C88C-1458-40A6-801B-97B5C4F03C72Q38241710-88913976-027C-4ABA-98A1-2C012A0C1D0EQ39350215-ECC9069D-EA9F-4AB1-95A0-EC7C916C65ACQ40861312-E73057D9-9F9F-4712-9EDA-778AAE0D8F62Q42086661-791B5A48-05A5-49AE-8BCD-1CF225634D7BQ43061556-D3CC4A01-37B6-43BA-8558-D8216D3BAA04Q48209875-E5EA7F9E-A9E2-47B7-AF14-31D7FAE77EAEQ50063069-FC2A4834-0B97-4F03-BC54-81AEFE6A6651Q50085453-85A7A069-59EF-4CB4-8F0A-2F9129F4AD24Q51353137-BF1BC2D6-B280-4378-A568-17690E73E09DQ56896789-2BC15720-DC2C-4611-9FA2-475CACFB6C44Q58754943-D3DFA0E2-1087-4396-8727-8D7BFC5CCEF0
P2860
Thrombotic microangiopathy after renal transplantation in the United States.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Thrombotic microangiopathy after renal transplantation in the United States.
@ast
Thrombotic microangiopathy after renal transplantation in the United States.
@en
type
label
Thrombotic microangiopathy after renal transplantation in the United States.
@ast
Thrombotic microangiopathy after renal transplantation in the United States.
@en
prefLabel
Thrombotic microangiopathy after renal transplantation in the United States.
@ast
Thrombotic microangiopathy after renal transplantation in the United States.
@en
P2093
P1476
Thrombotic microangiopathy after renal transplantation in the United States.
@en
P2093
Christina M Yuan
Joel C Reynolds
Kevin C Abbott
Lawrence Y Agodoa
P304
P356
10.1016/J.AJKD.2003.07.008
P577
2003-11-01T00:00:00Z